The global bio-vanillin market size was valued at USD 121.7 million in 2017. Growing consumption in pharmaceuticals, confectionery, and fragrances as a flavoring agent is expected to propel global bio-vanillin industry over the
Increasing adoption of the chemical for making cakes, ice creams, beverages, and chocolates is expected to result in high demand for natural vanillin over the coming years. The global confectionery industry revenue exceeded USD 180 billion in 2017. Increasing consumer spending, changing dietary habits, and a growing population is expected to augment confectionery consumption over the coming years, which in turn, will propel the global natural vanillin market over the projected period.
The global Bio-Vanillin market is anticipated to increase at a ~7.4 % CAGR to reach value USD ~255.2 Mn in 2032
Biotechnological methods to derive bio-vanillin with negligible or no toxic waste and minimal environmental impact is expected to increase the market concentration of bio-vanillin. Moreover, increased health consciousness over the past few years has shifted consumer preference from synthetic to biobased products. Furthermore, the Food and Drug Administration (FDA) and European Food Safety Authority (EFSA) have created quality and safety standards for ingredients to be used in food & beverages, which in turn is expected to increase the market concentration of bio-vanillin over the coming years.
High prices of natural vanillin coupled with supply shortage are expected to hamper the market conditions over the coming years. In addition, limited availability of natural vanillin by virtue of climate fluctuations will be a key market challenge. Furthermore, excess concentration of bio-vanillin is harmful in nature and may result in side effects such as toxicity for living cells. However, manufacturers operating in this industry are focusing on R&D for finding new processing technologies and bio-based raw material sources, which in turn is expected to be the global bio vanillin market prospectus over the coming years.
North America accounted for more than 17% of the global bio-vanillin market share in 2017. Rising consumption as a flavoring agent in the food & beverage industry in U.S. and Canada is expected to drive the market over the coming years. The U.S. accounted for more than 70% of overall North American bio-vanillin market demand in 2017. More than 40,000 grocery stores and increasing non-traditional food sellers in the U.S. is expected to provide lucrative growth for bio-vanillin market size. In addition, the presence of more than 150,000 convenience stores in the U.S. has generated more than USD 170 billion in 2017, which in turn is expected to be a favorable factor for the bio-vanillin market.
Middle East beauty market was valued more than USD 30 billion in 2017 and accounted for more than 5% of the global beauty market. In addition, in 2017, fragrance accounted for more than 15% of the beauty and personal care market in Middle East & Africa. Increased per capita spending on personal care products is expected to increase demand for bio-vanillin in fragrance industry over the projected period.
Increasing pharmaceutical sales coupled with well-established pharmaceutical manufacturers such as Accord, Novo Nordisk, Boehringer Ingelheim, AstraZeneca, Teva Pharmaceutical Industries, GlaxoSmithKline, Sanofi, Novartis, Roche, and Bayer is expected to increase the concentration of the bio-vanillin market in the European pharmaceutical industry. Increased usage in the pharmaceutical industry in the processing of medicines to eliminate foul taste and odor is expected to increase its market concentration in the European pharmaceutical industry.
The global bio-vanillin market is competitive in nature as a large number of well-established and small producers are operating in this market. Key manufacturers are Evolva, Solvay, De Monchy Aromatics, Advanced Biotech, Comax MFG Corp., Beijing LYS Chemicals Co., Ltd., Aurochemicals, BERJÉ INC., Borregaard, and Jiaxing Zhonghua Chemical Co., LTD.
Operating in the global bio-vanillin industry are focusing on increasing their production capacity to cater to the growing industry requirements. For instance, in 2017, Solvay, a Belgian chemical company specialized in advanced materials and specialty chemicals, nearly doubled its natural vanillin production. Moreover, increased health concerns and demand for clean labeling has encouraged producers to introduce natural vanilla ingredients in the product portfolio. For instance, in 2016, Solvay launched Vanifolia with functional and natural vanilla ingredients to enhance taste and flavor.
Bio-Vanillin Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2032 |
Study Period | 2018-2032 |
Forecast Unit | Value (USD) |
Revenue forecast in 2032 | USD ~255.2 Mn |
Growth Rate | CAGR of 7.4 % during 2022-2032 |
Segment Covered | by Application, Source, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Evolva Holding, Firmenich SA, Solvay, De Monchy Aromatics, Advanced Biotech, Givaudan, Omega Ingredients Limited, ENNOLYS, Comax MFG Corp, Beijing LYS Chemicals Co., ADM, Axxence Aromatic GmbH, Archer Daniels Midland Company, BERJÉ INC, Champon Vanilla Inc, Borregaard, Jiaxing Zhonghua Chemical Co., Shanghai Xinjia Perfume Co., Le Saffre, Zibo Svolei Fragrance Co., Ltd., Takasago International Corporation, Suzhou Function Group Co Ltd, and Apple Flavor & Fragrance Group Co. |
Key segments of the global bio-vanillin market
Application Overview (USD Million)
- Food & Beverages
- Fragrances
- Pharmaceuticals
Regional Overview (USD Million)
- North America
- U.S.
- Europe
- Germany
- UK
- France
- Asia-Pacific
- China
- Japan
- India
- Middle East & Africa
- Latin America
- Brazil